With a market cap of $14.5 billion, Solventum Corporation (SOLV) is a global healthcare company. The Maplewood, Minnesota-based company develops and manufactures medical and surgical products, advanced wound care solutions, dental and orthodontic products, and healthcare software designed to improve patient outcomes and streamline clinical workflows.
The leading global healthcare company is expected to announce its fiscal third-quarter earnings for 2026 after the market closes on Thursday, Nov. 5. Ahead of the event, analysts expect SOLV to report a profit of $1.35 per share on a diluted basis, down 10% from $1.50 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.